No photo of Edward W Greeno
Contact Expert

View Scopus Profile

Edward W Greeno

1992 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic AdenocarcinomaTRYbeCA-1 - Trial of Eryaspase in pancreatic Cancer

Greeno, E. W.

ERYTECH PHARMA, INC

10/1/18 → 10/30/22

Project: Research project

    • Phase 1-2 Study of ADI-PEG 20 plus FOLFOX in Subjects withAdvanced Gastrointestinal Malignancies

    Greeno, E. W.

    Polaris Pharmaceuticals, Inc.

    12/1/17 → 11/30/22

    Project: Research project

    • A Phase 3, Randomized, Double-Blind, Placebo-Controlled,

    Greeno, E. W.

    HALOZYME, INC.

    4/28/16 → 5/31/21

    Project: Research project

    • A Phase 2, Randomized, Double-Blind, Placebo-Controlled

    Greeno, E. W.

    ASTELLAS PHARMA, INC.

    2/1/16 → 2/28/21

    Project: Research project

    • A Phase 3 Randomized, Open-Label Study comparing Pexa-Ve

    Greeno, E. W.

    SILLAJEN USA, INC.

    1/1/16 → 9/30/20

    Project: Research project

    • Research Output

    Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies

    Hurwitz, H., Van Cutsem, E., Bendell, J., Hidalgo, M., Li, C. P., Salvo, M. G., Macarulla, T., Sahai, V., Sama, A., Greeno, E. W., Yu, K. H., Verslype, C., Dawkins, F., Walker, C., Clark, J. & O’Reilly, E. M., Aug 1 2018, In : Investigational New Drugs. 36, 4, p. 683-695 13 p.

    Research output: Contribution to journal › Article

    • 13 Scopus citations

    Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)

    Goldstein, D., Von Hoff, D. D., Moore, M., Greeno, E., Tortora, G., Ramanathan, R. K., Macarulla, T., Liu, H., Pilot, R., Ferrara, S. & Lu, B., Jan 2016, In : European Journal of Cancer. 52, p. 85-91 7 p.

    Research output: Contribution to journal › Article

    Open Access
    • 17 Scopus citations

    RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4

    Kirby, M. K., Ramaker, R. C., Gertz, J., Davis, N. S., Johnston, B. E., Oliver, P. G., Sexton, K. C., Greeno, E. W., Christein, J. D., Heslin, M. J., Posey, J. A., Grizzle, W. E., Vickers, S. M., Buchsbaum, D. J., Cooper, S. J. & Myers, R. M., Oct 1 2016, In : Molecular Oncology. 10, 8, p. 1169-1182 14 p.

    Research output: Contribution to journal › Article

    Open Access
    • 16 Scopus citations

    Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors

    Strosberg, J. R., Fisher, G. A., Benson, A. B., Anthony, L. B., Arslan, B., Gibbs, J. F., Greeno, E., Iyer, R. V., Kim, M. K., Maples, W. J., Philip, P. A., Wolin, E. M., Cherepanov, D. & Broder, M. S., Feb 28 2015, In : World journal of gastroenterology. 21, 8, p. 2450-2459 10 p.

    Research output: Contribution to journal › Article

    • 11 Scopus citations

    Neoadjuvant interferon-based chemoradiation for borderline resectable and locally advanced pancreas cancer: A Phase II pilot study

    Jensen, E. H., Armstrong, L., Lee, C. K., Tuttle, T. M., Vickers, S. M., Sielaff, T. & Greeno, E. W., Feb 2014, In : HPB. 16, 2, p. 131-139 9 p.

    Research output: Contribution to journal › Article

    • 9 Scopus citations